Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

September 21, 2020 by Alan Khadavi

Xolair for Nasal Polyps

The treatment of Xolair for nasal polpys is currently being investigated. Chronic sinusitis with nasal polyps is common and is estimated to affect up to 15% of the population. It is associated with adult onset asthma. Many patients have uncontrolled symptoms despite use of nasal steroids. Even after surgery up to 80% of patients can experience a recurrence of symptoms.

Besides nasal steroids, Dupixent is currently the only approved biological medication approved for nasal polyps. IgE is thought to play a central role in the growth of polyps by activating mast cells, basophils and eosinophils. Currently Xolair (omalizumab) has an indication for moderate to severe persistent asthma and chronic idiopathic urticaria.

Omalizumab (Xolair) for treating Angioedema and Chronic Hives

A recent study looked at two 24-week Phase 3 trials (POLYP 1 and POLYP 2) that evaluated the safety and efficacy of the anti-IgE monoclonal antibody, xolair, in patients with chronic sinusitis and nasal polyps after intranasal steroid treatment.

From as early as 4 weeks to study end, treatment with Xolair showed:

  • reductions in nasal polyp size
  • improvements in symptoms including nasal congestion and loss of smell
  • improvements in disease-related quality of life.

Safety results were consistent with Xolair and the most common adverse events observed were headache, injection site reactions, arthralgia, dizziness and upper abdominal pain. Rare events such as anaphylaxis were not observed in these trials.

Nasal polyps are very difficult to treat as nasal steroids are inadequate. Oral steroids help, but long term use can cause significant side effects. Surgery is initially effective, but the polyps can back in the majority of patients. Dupilumab has been shown to be helpful in many patients. In this study, another future option may be Xolair, which could be a viable alternative for patients who fail the above therapies.

It remains to be seen whether or not Xolair for nasal polyps will be a new indication. Check back for future updates on this medication.

Xhance for Nasal Polyps

Potential new Nasal Polyps Treatment option

Mepolizumab (Nucala) for Nasal Polyps

Dupilumab for Nasal Polyps

_______________________________________________________________________________________________________________________

Update December 2, 2020

Xolair for nasal polyps just received FDA approval. It is for add on therapy for patients 18 years and older who have failed nasal steroids.

“With Xolair, we observed significantly reduced nasal polyps and congestion symptoms in adults who had nasal polyps in two pivotal Phase III studies,” said Joseph Han, MD, Chief of the Division of Rhinology and the Division of Allergy at Eastern Virginia Medical School and study investigator of the POLYP 1 and POLYP 2 trials. “Xolair provides a new option for treating these patients, who often have other respiratory and allergic conditions that may further worsen symptoms.”

Novartis announces FDA approval of Xolair® (omalizumab) for adults with nasal polyps

The dosing for nasal polyps for Xolair is based on the total IgE level (IU/ml) and the weight of the patient. It is dosed from 75mg to 600mg every 2 to 4 weeks.

 

 

 

Filed Under: biologics, Blog

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page